Search
Search Results
##search.searchResults.foundPlural##
-
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2640PDF: 1074HTML: 113 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1381PDF: 814HTML: 3118 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3220PDF: 1004HTML: 2023 -
THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia
1006PDF: 857Suppl. Files: 455HTML: 284 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2687PDF: 1002HTML: 2265 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1600PDF: 880HTML: 3154Figure 5: 154Figure 4: 157Figure 3: 191Figure 1: 170Figure 2: 165 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3864PDF: 1469HTML: 8510 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1599PDF: 795HTML: 1228Figure 1: 172Figure 2: 184Figure 3: 182 -
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
931PDF: 455HTML: 113 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1374PDF: 1303HTML: 94 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1833PDF: 831HTML: 1579 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3316PDF: 582HTML: 655 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1563PDF: 843HTML: 1031Picture 1: 166 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1583PDF: 970HTML: 186 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1815PDF: 794HTML: 3599 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4242PDF: 1172HTML: 2151Figure 1: 163 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
717PDF: 464HTML: 6264 -
A HEALTH RELATED QUALITY OF LIFE AND PSYCHOPATHOLOGICAL SYMPTOMS IN PEOPLE WITH HEMOPHILIA, BLOODBORNE CO-INFECTIONS AND COMORBIDITIES: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY PSYCHOLOGICAL DINAMICS OF A GROUP OF ITALIAN HEMOPHILIACS WITH AND WITHOUT (CO)INFECTIONS AND COMORBIDITIES: A MULTICENTER STUDY
1427PDF: 1206HTML: 500 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4480PDF: 1916HTML: 17733 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7924PDF: 4102HTML: 7358 -
Seroprevalence of transfusion-transmissible infections among family replacement donors and voluntary non-remunerated blood donors during the COVID-19 pandemic in sub Saharan Africa family replacement donors and voluntary non-remunerated blood donors in transfusion transmissible infections
1555PDF: 1284HTML: 144 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1161PDF: 823HTML: 2179Figue 1: 172







